-
US indices finished yesterday's trading lower. S&P 500 dropped 1.48%, Dow Jones finished 0.46% lower and Nasdaq slumped 3.02%. Russell 2000 plunged 2.94%
-
Stocks in Asia dropped as well. Nikkei dropped 1.4%, S&P/ASX 200 declined 0.5%, Kospi moved 0.9% lower and indices from China traded 2-3% lower
-
DAX futures point to a lower opening of the European session
-
Bank of Japan dropped the 6 trillion JPY ETF buy target but maintained the 12 trillion JPY ETF buy ceiling. The band also expanded 10-year yield trading band to 25 bps (was 20 bps)
-
Germany, France and Italy plan to resume the AstraZeneca vaccine rollout today after EMA ruled that the vaccine is safe to use. Canadian authorities said that benefits of AstraZeneca vaccine outweigh risks
-
US officials said that high level talks with China in Alaska were substantive and serious. However, earlier reports suggested that talks are not going smooth
-
Ford will suspend some production amid chip shortages
-
Bitcoin trades slightly below $58,000 mark
-
Oil is trading slightly lower following a massive plunge yesterday. Brent trades near $62.50 while WTI dropped below $60 mark
-
Precious metals trade mixed - gold, silver and platinum gain slightly while palladium pulls back
-
CHF and JPY are the best performing major currencies while AUD and GBP lag the most
Oil took a massive hit yesterday. WTI dropped below the upward trendline and continued to move lower. Price dropped below $60 per barrell and reach a low at the 50-session moving average. Commodity managed to recover above $59 swing area but pressure remains. Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
